Follicular thyroid carcinoma: From diagnosis to treatment

Endocrine Journal

Volumn 53, Issue 4, 2006, Pages 441-448

  Lin, Jen Der ^a,b   Chao, Tzu Chieh ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Dedifferentiation; Gene therapy; Minimal invasive follicular carcinoma; Sodium iodide symporter; Total thyroidectomy

Indexed keywords

ENDOSTATIN; FLUORODEOXYGLUCOSE F 18; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; TECHNETIUM 99M; TETROFOSMIN; TRANSCRIPTION FACTOR PAX8; TROGLITAZONE; TUMOR MARKER; Y BOX BINDING PROTEIN 1;

ANAPLASTIC CARCINOMA; ANTIANGIOGENIC ACTIVITY; ASPIRATION BIOPSY; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CELL DIFFERENTIATION; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG EFFECT; DRUG INHIBITION; FOLLICULAR CARCINOMA; FROZEN SECTION; GENE EXPRESSION; GENE THERAPY; HUMAN; IN SITU HYBRIDIZATION; LUNG METASTASIS; MICROARRAY ANALYSIS; NONHUMAN; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SOFT TISSUE METASTASIS; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; DIAGNOSTIC IMAGING; HUMANS; IODINE RADIOISOTOPES; PREDICTIVE VALUE OF TESTS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 33748473574     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.KR-77     Document Type: Review

References (72)

1. Okuda S, Kanda F, Kawamoto K, Chihara K (2004) Subacute bulbar palsy as the initial sign of follicular thyroid cancer. Intern Med 43: 997-999.
2. Lin JD, Chao TC, See LC, Weng HF, Ho YS (1998) Poor prognosis of 56 follicular thyroid carcinomas with distant metastases at the time of diagnosis. Cancer J 11: 190-195.
3. Rosahl SK, Erpenbeck V, Vorkapic P, Samii M (2000) Solitary follicular thyroid carcinoma of the skull base and its differentiation from ectopic adenoma-review, use of galectin-3 and report of a new case. Clin Neurol Neurosurg 102: 149-155.
4. Kondo T, Katoh R, Omata K, Oyama T, Yagawa A, Kawaoi A (2000) Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid. Pathol Int 50: 509-513.
5. Reynolds RM, Weir J, Stockton DL, Brewster DW, Sandeep TC, Strachan MW (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 62: 156-162.
6. Lin JD, Chao TC, Sun JH, Ho C, Weng HF (2000) Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology 58: 280-285.
7. Rajesh L, Saha M, Radhika S, Das Radotra B, Rajwanshi A (2004) Morphometric image analysis of follicular lesions of the thyroid. Anal Quant Cytol Histol 26: 117-120.
8. Farahati J, Geling M, Mader U, Mortl M, Luster M (2004) Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. Thyroid 14: 141-147.
9. Lin JD, Kao PF, Weng HF, Lu WT, Huang MJ (1998) Relative value of thallium-201, and iodine-131 scans in the detection of the recurrence or distant metastasis of well differentiated thyroid carcinoma. Eur J Nucl Med 25: 695-700.
10. Kumnig G (2002) Value of F-18 fluorodeoxyglucose positron emission tomography in thyroid carcinoma. Wien Med Wochenschr 152: 280-285.
11. Erdem S, Bashekim C, Kizilkaya E, Ince M, Karsli F (1997) Clinical application of Tc-99m tetrofosmin scintigraphy in patients with cold thyroid nodules. Comparison with color Doppler sonography. Clin Nucl Med 22: 76-79.
12. Krenik E, Gallowitsch HJ, Mikosch P, Molnar M, Pipan W, Gomez I, Lind P (1997) Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. Eur J Nucl Med 24: 716-721.
13. Bloom AD, Adler LP, Shuck JM (1993) Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114: 728-734.
14. Shechtman L, Koren R, Horowitz A, Shechtman I, Halpern M, Gal R (1998) Diagnostic value of AgNOR staining in thyroid cytology. Anal Quant Cytol Histol 20: 187-191.
15. Lin JD, Hsueh C, Chao TC, Weng HF, Huang BY (1997) Thyroid follicular neoplasm diagnosed by high resolution ultrasonography with fine needle aspiration cytology. Acta Cytol 41: 687-691.
16. Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE (2004) Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188: 459-462.
17. Dosen D, Turic M, Smalcelj J, Janusic R, Grgic MP, Separovic V (2003) The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Head Neck 25: 521-528.
18. Paphavasit A, Thompson GB, Hay ID, Grant CS, van Heerden JA, Ilstrup DM, Schleck C, Goellner JR (1997) Follicular and Hürthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 132: 674-679.
19. Ferreira JA, Myers JD, Bostwick DG (1995) Accuracy of frozen section diagnosis in surgical pathology. Review of a 1-year experience with 24,880 cases at Mayo Clinic, Rochester. Mayo Clinic Proc 70: 1137-1141.
20. McHenry CR, Raeburn C, Strickland T, Marty JJ (1996) The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg 172: 658-661.
21. Kingstorn GW, Bugis SP, Davis N (1992) Role of frozen section and clinical parameters in distinguishing benign from malignant follicular neoplasms of the thyroid. Am J Surg 164: 603-605.
22. Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, Tsujimoto M, Kakudo K (2002) Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 26: 1509-1514.
23. Udelsman R, Westra WH, Donovan PI, Sohn TA, Carmeron JL (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233: 716-722.
24. Duek SD, Goldenberg D, Linn S, Krausz MM, Hershko DD (2002) The role of fine-needle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg Today 32: 857-861.
25. Monzani F, Caraccio N, Iacconi P, Faviana P, Dardano A, Basolo F, Miccoli P (2003) Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis? Thyroid 13: 389-394.
26. Franc B, de la Salmoniere P, Lange F, Hoany C, Louvel A, de Roquancourt A, Vilde F, Hejblum G, Chevret S, Chastang C (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34: 1092-1100.
27. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 13: 1234-1242.
28. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C (2003) Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63: 2864-2871.
29. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2004) High-through put differential screening of mRNAs by analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 90: 1600-1605.
30. Volante M, Bozzalla-Cassione F, Orlandi F, Papotti M (2004) Diagnostic role of galectin-3 in follicular thyroid tumors. Virchows Arch 444: 309-312.
31. Maruta J, Hishimoto H, Yamashita H, Yamashita H, Noguchi S (2004) Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Arch Surg 139: 83-88.
32. Dwight T, Thoppe SR, Foukakis T, Lui WO, Wallin G, Hoog A, Frisk T, Lasson C, Zedenius J (2003) Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88: 4440-4445.
33. Rickert D, Mittermayer C, Lindenfelser R, Biesterfeld S (2000) MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Anal Quant Cytol Histol 22: 229-234.
34. Maximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simoes M (2004) Core I gene is overexpressed in Hürthle and non-hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC Cancer 4: 12.
35. Mase T, Funahashi H, Koshikawa T, Imai T, Nara Y, Tanaka Y, Nakao A (2003) HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J 50: 173-177.
36. Nasir A, Catalano E, Calafati S, Cantor A, Kaiser HE, Coppola D (2004) Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid. In vivo 18: 189-195.
37. Kammori M, Nakamura K, Hashimoto M, Ogawa T, Kaminishi M, Takubo K (2003) Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int J Oncol 22: 985-991.
38. McIver B, Grebe SK, Eberhardt NL (2004) The PAX8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma. Curr Drug Targets Immune Endocr Metabol Disord 3: 221-234.
39. Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88: 354-357.
40. Marques AR, Espadinha C, Frias MJ, Rogue L, Catarino AL, Sobrinho LG, Leite V (2004) Underexpression of peroxisome proliferator-activated receptor (PPAR) gamma in PAX/PPARgamma-negative thyroid tumours. Br J Cancer 91: 732-738.
41. Hibi Y, Nagaya T, Kambe F, Imai T, Funahashi H, Nakao A, Seo A (2004) Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax-PPAR gamma fusion mRNA? Endocr J 51: 361-366.
42. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd (2003) Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9: 1792-1800.
43. Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variable of papillary and follicular thyroid carcinomas with lymph node metastases and no distant metastases. Endocr-Relat Cancer 6: 109-115.
44. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR (2003) Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197: 191-197.
45. Zettinig G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, Niederle B (2002) Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma - surgery or conventional therapy? Clin Endocrinol 56: 377-382.
46. Min JJ, Chung JIK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC, Cho BY (2001) Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 28: 639-645.
47. Dackiw AP, Ezzat S, Huang P, Liu W, Asa SL (2004) Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. Endocrinology 145: 5840-5846.
48. Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck-Loebenstein B (1994) Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett 87: 65-71.
49. Schroder-van der Elst JP, van der Heide D, Romijn JA, Smit JW (2004) Differential effects of natural flavonoids on growth and iodide content in a human Na+/I-symporter-transfected follicular thyroid carcinoma cell line. Eur J Endocrinol 150: 557-564.
50. Schmutzler C, Hoang-Vu C, Ruger B, Kohrle J (2004) Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. Eur J Endocrinol 150: 547-556.
51. Wang MY, Lin MT, Liaw KY (2002) Operative strategy in follicular thyroid cancer. J Formos Med Assoc 101: 820-825.
52. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95: 488-498.
53. Randolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12: 989-996.
54. Lin JD, Kao PF, Chao TC (1998) The effects of radioactive iodine in the thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Br J Radiol 71: 307-313.
55. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23: 205-211.
56. Vanhaverbeke G (2004) Follicular carcinoma of the thyroid with poorly differentiated component presenting with an ileal osteoblastic metastasis. Thyroid 14: 858-861.
57. 53 mutation in thyroid carcinoma. Cancer Letter 103: 57-63.
58. Ito Y, Yoshida H, Shibahara K, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Uchimi T, Kuwano M, Miyoshi E, Matsuura W, Kuma K, Miyauchi A (2003) Y-box binding protein expression in thyroid neoplasm: its linkage with anaplastic transformation. Pathol Int 53: 429-433.
59. Asakawa H, Kobayashi T (2002) Multistep carcinogenesis in anaplastic thyroid carcinoma: a case report. Pathology 34: 94-97.
60. Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Pathology 34: 239-244.
61. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277: 27872-27879.
62. Xu G, Pan J, Martin C, Yeung SC (2001) Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J Clin Endocrinol Metab 86: 1769-1777.
63. Park JW, Zarnegar R, Kanauchi H, Wong MG, Hyun WC, Ginzinger DG, Lobo M, Cotter P, Duh QY, Clark OH (2005) Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid 15: 222-231.
64. Hermanek P, Scheibe O, Spiessl B (1987) UICC: TNM classification of malignant tumors. In: ROFO Fortschr Geb Rongenstr Nuklearmed, 4th ed. Springer-Verlag, Berlin, 732.
65. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M (1979) A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15: 1033-1041.
66. Hay ID, Grant CS, Taylor WF, McConahey WM (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095.
67. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
68. Hay ID, Bergstralh EJ, Geollner JR, Ebersold JR, Grand CS (1993) Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 thorough 1989. Surgery 114: 1050-1058.
69. D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE, Clark OH (2004) Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 14: 453-458.
70. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100: 1123-1129.
71. Tzen CY, Huang YW, Fu YS (2003) Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 34: 666-669.
72. Kato N, Tsuchiya T, Tamura G, Motoyama T (2002) E-cadherin expression in follicular carcinoma of the thyroid. Pathol Int 52: 13-18.